Tirzepatide vs Ozempic: Results and Canadian Pricing

The tirzepatide vs Ozempic question usually comes down to three things: how the two molecules differ, which performs better in head-to-head research, and what each actually costs in Canada. The first two have published answers. The third is where the conversation gets interesting — because the pharmacy price of tirzepatide and the price of the same molecule as a research vial are not remotely the same number.

Quick Breakdown: Tirzepatide vs Ozempic

What Each One Actually Is

Semaglutide — sold as Ozempic for diabetes and Wegovy for weight management — is a GLP-1 receptor agonist. It mimics a gut hormone that slows gastric emptying, increases satiety signalling, and improves glucose-dependent insulin release. It is the molecule that defined this category, and it has the longest safety record of any of them.

Tirzepatide adds a second receptor. GIP agonism works alongside GLP-1 to influence appetite regulation and fat metabolism through a different pathway, and the combination is why tirzepatide is generally discussed as a step beyond single-incretin compounds. For the mechanism in more detail, read what tirzepatide is and how dual-incretin agonism works.

Which One Performs Better

This has been tested directly. The SURPASS-2 trial compared tirzepatide at 5, 10 and 15 mg against semaglutide 1 mg over 40 weeks in people with type 2 diabetes. Tirzepatide produced greater reductions in both body weight and HbA1c at every dose tested. That result is the reason tirzepatide became the reference point for the next generation of incretins rather than another me-too GLP-1.

Side Effects

They overlap almost entirely, because the mechanism overlaps: nausea, vomiting, diarrhoea, constipation, and injection-site reactions, clustering around dose escalation. Tirzepatide adds GIP activity but does not introduce a new side-effect family. Both are titrated for the same reason — GI tolerability at higher doses — and both see a meaningful minority of users discontinue for that reason.

For the full picture on the newer compound, see the retatrutide guide — the pattern is the same across the class.

What Each Costs in Canada

This is where the two products genuinely diverge, and where "which is cheaper" has a surprising answer.

Read that table carefully and the strategic picture appears. Generic semaglutide has reset the price of the single-agonist route at around $100 a month. Pharmacy tirzepatide still costs three to six times that. A tirzepatide vial at $80 for 20 mg — enough for a month at 5 mg a week — sits below the generic semaglutide price while being the dual agonist.

In other words: if price is why you were considering Ozempic, that argument no longer holds the way it did in 2024.

And both sit behind the same gate. A prescription, an appointment, and an insurer's approval stand between you and either molecule — which is a bigger practical barrier than the difference between them.

Frequently Asked Questions

Is tirzepatide stronger than Ozempic?

In the SURPASS-2 head-to-head, yes — greater average weight loss and A1c reduction than semaglutide 1 mg at all three doses tested.

Can I switch from Ozempic to tirzepatide?

That is a protocol decision rather than a sourcing one. The cost comparison is simple either way: at 5 mg a week, a tirzepatide vial runs $80 a month against $258–$282 for brand Ozempic and $88.88–$103.53 for generic semaglutide.

Why is tirzepatide so much cheaper as a research vial?

Because you are buying peptide by the milligram rather than paying for a regulated dispensing chain, pharmacy margin and insurer overhead. The molecule is the same; the supply chain is not.

Which is better for weight loss?

Tirzepatide showed the larger effect in direct comparison, semaglutide has the longer evidence base. Both are prescription medicines when bought as medicines — and both are sold as research materials in the lyophilized form.

Where can I buy tirzepatide in Canada?

From a Canadian research supplier. Our tirzepatide vials are priced by strength, dispatched from British Columbia in 24–48 business hours, and each batch's certificate of analysis is published on the product page under the same batch number on the vial.